Erin is a trailblazer in the fields of peptide therapy, hormone optimization, and cellular medicine. With a wealth of experience in founding and consulting for organizations at the forefront of these innovative areas, she has become a trusted advisor to providers, investors, and institutions looking to integrate advanced medical protocols into their portfolios. Erin’s work in the digital health space, as well as her leadership roles with prestigious organizations such as Deloitte Consulting and the Centers for Disease Control (CDC), highlights her ability to merge science, technology, and healthcare to create impactful solutions.

From cardiac physiology research at the University of Michigan Medical School to infectious disease care standards at the CDC, Erin’s diverse background is rooted in a passion for improving lives. Holding dual Master’s degrees in Public Health and Business Administration from Emory University, Erin continues to shape the future of medicine. When not working, she enjoys staying active, exploring nature, and spending time with her family and dogs in Los Angeles.